Nephrological aspects of surgical weight correction in morbid obesity


Cite item

Full Text

Abstract

Obesity, including morbid obesity, is a growing worldwide problem. The adverse effect of obesity on the kidneys is associated with the development of comorbid conditions, such as insulin resistance (IR), metabolic syndrome (MS), diabetes mellitus (DM), arterial hypertension (AH), which are the recognized risk factors of chronic kidney disease (СKD). Obesity also causes direct kidney damage with the development of non-immune focal segmental glomerulosclerosis. The leading pathophysiological mechanisms of kidney damage in obesity are intrarenal hemodynamic disorders with the formation of hyperfiltration and damaging effects of adipokines produced by adipose tissue. Bariatric surgery (BS) has taken a leading position in the treatment of morbid obesity, demonstrating its effectiveness not only in long-term weight loss, but also in the correction of IR, MS, DM, AH. Nephroprotective effect of significant and persistent weight loss is caused by the elimination of hyperfiltration and damaging effect of adipokines. Results of the observational studies of the immediate and long-term effects of BS have demonstrated positive renal outcomes, in particular, the decrease in albuminuria/proteinuria, the improvement or stabilization of glomerular filtration rate, the delay of end-stage renal failure development; surgical correction of body weight in dialysis patients with morbid obesity lets them realize subsequent kidney transplantation. Large, randomized prospective studies with a longer follow-up are needed; analysis of the long-term renal consequences of BS in obesity patients with pre-existing renal impairment, including dialysis patients, is required; stratification of the BS risk of renal complications (acute kidney damage, nephrolithiasis, nephrocalcinosis) and effective strategy for managing these risks need to be developed.

About the authors

I N Bobkova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: irbo.mma@mail.ru
д.м.н., проф. каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета; тел.: 8(917)559-71-432; ORCID № 0000-0002-8007-5680 Moscow, Russia

S S Gussaova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

аспирант каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета Moscow, Russia

E V Stavrovskaya

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

доц. каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета Moscow, Russia

A V Struve

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

студент Международной школы «Медицина будущего» научно-технологического парка биомедицины Moscow, Russia

References

  1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8
  2. Ковесди Ч., Фурс С., Зоккали К. Ожирение и заболевания почек: скрытые последствия эпидемии. Нефрология. 2017;21(2):10-9.
  3. World Health Organization (WHO), Fact Sheet No.311 (updated March 2013). Available at: http://www.who.int/mediacentre/factsheets/ fs311/en/
  4. Fruhbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert J.M. Obesity: The gateway to ill health - an EASO Position Statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6:117-20. doi: 10.1159/000350627
  5. Forouzanfar M.H, Alexander L, Anderson H.R, Bachman V.F, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;86:2287-323. doi: 10.1016/S0140-6736(15)00128-2
  6. Díaz M.N. Consequences of morbid obesity on the kidney. Where are we going? Clin Kidney J. 2016;1-6. doi: 10.1093/ckj/sfw094
  7. Aneja A, El-Atat F, Mc Farlane S.I, Sowers J.R. Hypertension and obesity. Recent Progr Horm Res. 2004;59:169-206. doi: 10.1210/rp.59.1.169
  8. Rosenberg D.E, Jabbour S.A, Goldstein B.J. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabet Obes Metab. 2005;7:642-53. doi: 10.1111/j.1463- 1326.2004.00446.x
  9. Zalesin K.C, Mc Cullough P.A. Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients. Adv Chronic Kidney Dis. 2006;13:403-17. doi: 10.1053/j.ackd.2006.07.008
  10. Rosenberg D.E, Jabbour S.A, Goldstein B.J. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabet Obes Metab. 2005;7:642-53. doi: 10.1111/j.1463-1326.2004.00446.x
  11. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911-9. doi: 10.1016/j.jaci.2005.02.023
  12. Кутырина И.М. Гломерулопатия, ассоциированная с ожирением. Терапевтический архив. 2017;89(6):97-101. doi: 10.17116/terarkh201789697-101
  13. D’Agati V.D, Chagnac A, de Vries A.P.J, et al. Obesity - related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12:453-71. doi: 10.1038/nrneph.2016.75
  14. Shen W.W, Chen H.M, Chen H, et al. Obesity - related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol. 2010;5:1401-9. doi: 10.2215/CJN.01370210
  15. Helal I, Fick-Brosnahan G.M, Reed-Gitomer B, Schrier R.W. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8:293-300. doi: 10.1038/nrneph.2012.19
  16. Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, et al. Obesity - induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008;23:3946-52. doi: 10.1093/ndt/gfn379
  17. Крячкова А.А., Савельева С.А., Галлямов М.Г., Шестакова М.В., Кутырина И.М. Роль ожирения в поражении почек при метаболическом синдроме. Нефрология и диализ. 2010;(12):34-9.
  18. Кутырина И.М., Савельева С.А., Крячкова А.А., Шестакова М.В. Вклад ожирения в поражение почек у больных сахарным диабетом 2 типа. Терапевтический архив. 2010;(6):21-5.
  19. De Vries A, Ruggenenti P, Ruan X, et al. Fatty kidney: emerging role of ectopic lipid in obesity - related renal disease. Lancet Diabet Endocrinol. 2014;2(5):417-26. doi: 10.1016/s2213-8587(14)70065-8
  20. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allerg Clin Immunol. 2005;115:911-9. doi: 10.1016/j.jaci.2005.02.023
  21. Berthoux F, Mariat C, Maillard N. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy. Nephrol Dial Transplant. 2013;28 (suppl.4):iv160-iv166. doi: 10.1093/ndt/gft286
  22. Kataoka H, Ohara M, Shibui K, et al. Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters. Clin Exp Nephrol. 2012;16(5):706-12. doi: 10.1007/s10157-012-0613-7
  23. Chen H.M, Shen W.W, Ge Y.C, Zhang Y.D, Xie H.L, Liu Z.H. The relationship between obesity and diabetic nephropathy in China. BMC Nephrology. 2013;14:69. doi: 10.1186/1471-2369-14-69
  24. Retnakaran R, Cull C.A, Thorne K.I, et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55:1832-9. doi: 10.2337/db05-1620
  25. Arterburn D.E, Olsen M.K, Smith V.A, et al. Association between bariatric surgery and long - term survival. JAMA 2015;313:62-70. doi: 10.1001/jama.2014.16968
  26. Neovius M, Narbro K, Keating C, Peltonen M, Sjöholm K, Agren G, Sjöström L, Carlsson L. Health care use during 20 years following bariatric surgery. JAMA 2012;308:1132-41. doi: 10.1001/2012.jama.11792
  27. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822-32. doi: 10.1007/s11695-015-1657-z
  28. Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126-35. doi: 10.1007/s11695-014-1354-3
  29. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Rouxen-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236-42. doi: 10.1097/01.sla.0000133117.12646.48
  30. Rubino F, Marescaux J. Effect of duodenal - jejunal exclusion in a non - obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1-11. doi: 10.1097/01.sla.0000102989. 54824.fc
  31. Kawada T. Bariatric Surgery in Patients With Type 2 Diabetes Mellitus. Ann Surg. 2015. doi: 10.1097/SLA.0000000000001379
  32. Fried M, Yumuk V, Oppert J.M, Scopinaro N, Torres A, Weiner R, Yashkov Y, Frühbeck G. Interdisciplinary European guidelines on metabolic and bariatric surgery. International Federation for the Surgery of Obesity and Metabolic Disorders - European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO). Obes Surg. 2014 Jan;24(1):42-55. doi: 10.1007/s11695-013-1079-8
  33. Бондаренко И.З., Бутрова С.А., Гончаров Н.П., Дедов И.И., Дзгоева Ф.Х., Ершова Е.В., Ильин А.В., Лейтес Ю.Г., Мазурина Н.В., Мельниченко Г.А., Савельева Л.В., Трошина Е.А., Фадеев В.В., Шестакова М.В., Романцова Т.И., Яшков Ю.И., Евдошенко В.В., Феденко В.В., Егиев В.Н., Кривцова Е.В и др. Лечение морбидного ожирения у взрослых. Национальные клинические рекомендации. Ожирение и метаболизм. 2011;(3):75-83. doi: 10.14341/2071-8713-4844
  34. Chang A.R, Grams M.E, Navaneethan S.D. Bariatric Surgery and Kidney-Related Outcomes. Kidney Int Rep. 2017;2:261-70. doi: 10.1016/j.ekir. 2017.01.010
  35. Яшков Ю.И. О хирургичеcких методах лечения ожирения. Москва; 2016. 52 c.
  36. Brochner-Mortensen J, Rickers H, Balslev I. Renal function and body composition before and after intestinal bypass operation in obese patients. Scand J Clin Lab Invest. 1980;40(8):695-702. doi: 10.3109/ 00365518009095584
  37. Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant. 2013;0:1-17. doi: 10.1093/ndt/gft302
  38. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480-6. doi: 10.1097/01.asn.0000068462.38661.89
  39. Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long - term follow - up. J Am Soc Nephrol. 2006;17(12 suppl):S213-S217. doi: 10.1681/ASN.2006080917
  40. Serpa Neto A, Bianco Rossi F.M, Dal Moro Amarante R, et al. Effect of weight loss after Rouxen-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol. 2009;22:637-46.
  41. Lieske J.C, Collazo-Clavell M.L, Sarr M.G, et al. Gastric bypass surgery and measured and estimated GFR in women. Am J Kidney Dis. 2014;64:663-5. doi: 10.1053/j.ajkd.2014.06.016
  42. Friedman A.N, Moe S, Fadel W.F, et al. Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol. 2014;39:8-15. doi: 10.1159/000357231
  43. Navaneethan S.D, Yehnert H, Moustarah F, et al. Weight loss interventions in chronic kidney disease: a systematic review and meta - analysis. Clin J Am Soc Nephrol. 2009;4:1565-74. doi: 10.2215/CJN.02250409
  44. Ruiz-Tovar J, Giner L, Sarro-Sobrin F, Alsina M.E, Marco M.P, Craver L. Laparoscopic Sleeve Gastrectomy Prevents the Deterioration of Renal Function in Morbidly Obese Patients Over 40 Years. Obes Surg. 2014. doi: 10.1007/s11695-014-1486-5
  45. Schuster D.P, Teodorescu M, Mikami D, et al. Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis. 2011;7:459-64. doi: 10.1016/j.soard.2010.11.015
  46. Lee Ying Ngoh C, Bok Yan So J, Ho Yee Tiong, Shabbir A, Boon Wee Teo. Effect of weight loss after bariatric surgery on kidney function in a multiethnic Asian population. Surg Obes Relat Dis. 2016;12(3):600-5. doi: 10.1016/j.soard.2015.07.003
  47. Chang A.R, Chen Y, Still C, et al. Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int. 2016;90:164-71. doi: 10.1016/j.kint.2016.02.039
  48. Iman T.H, Fischer H, Jing B, et al. Estimated GFR before and after bariatric surgery in CKD. Am J Kidney Dis. 2016;69(3):380-8. doi: 10.1053/j.ajkd.2016.09.020
  49. Amor A, Jimenez A, Moize V, Ibarzabal A, Flores L, Lacy A.M. Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc. 2013;27:2046-51. doi: 10.1007/s00464-012-2708-3
  50. Li K, Zou J, Ye Z, Di J, Han X, Zhang H, et al. Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis. PLoS ONE. 2016;11(10):e0163907. doi: 10.1371/ journal.pone.0163907
  51. Lieske J.C, Mehta R.A, Milliner D.S, et al. Kidney stones are common after bariatric surgery. Kidney Int. 2015;87:839-45. doi: 10.1038/ ki.2014.352
  52. Sinha M.K, Collazo-Clavell M.L, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux - en-Y gastric bypass surgery. Kidney Int. 2007;72:100-7. doi: 10.1038/sj.ki.5002194
  53. Nasr S.H, D’Agati V.D, Said S.M, et al. Oxalate nephropathy complicating Roux - en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3:1676-83. doi: 10.2215/CJN.02940608
  54. Weingarten T.N, Gurrieri C, Mc Caffrey J.M, et al. Acute kidney injury following bariatric surgery. Obes Surg. 2013;23:64-70. doi: 10.1007/s11695-012-0766-1
  55. Abdullah H.R, Tan T.P, Vaez M, et al. Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery: a single - centre retrospective cohort study. Obes Surg. 2016;26:1493-9. doi: 10.1007/s11695-015-1938-6
  56. Ettinger J, Marcilio C, Santos-Filho P, et al. Rhabdomyolysis: diagnosis and treatment in bariatric surgery. Obes Surg. 2007;17:525-32. doi: 10.1007/s11695-007-9091-5
  57. Alexander J.W, Goodman H.R, Gersin K, et al. Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation. 2004;78:469-74. doi: 10.1097/01.tp.0000128858. 84976.27
  58. Mac Laughlin H.L, Hall W.L, Patel A.G, Macdougall I.C. Laparoscopic sleeve gastrectomy is a novel and effective treatment for obesity in patients with chronic kidney disease. Obes Surg. 2012;22:119-23. doi: 10.1007/s11695-011-0448-4
  59. Freeman C.M, Woodle E.S, Shi J, et al. Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy. Am J Transplant. 2015;15:1360-8. doi: 10.1111/ajt.13116

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies